Linzagolix with add-back Remedy accepted to be used inside NHS Scotland
Ladies in Scotland affected by endometriosis now have entry to a brand new remedy choice following the Scottish Medicines Consortium’s (SMC) acceptance of linzagolix with add-back remedy (ABT). The once-daily tablet is accredited for grownup ladies of reproductive age who’ve beforehand undergone medical or surgical remedy for the situation.
The choice aligns NHS Scotland with the remainder of the UK, the place linzagolix has already been accredited by the Nationwide Institute for Well being and Care Excellence (NICE) to be used in England, Wales and Northern Eire. Endometriosis impacts round one in ten ladies of reproductive age within the UK and may trigger continual pelvic ache, painful menstruation and important impacts on high quality of life.
Dr Fortunate Saraswat, Guide Gynaecologist and Honorary Senior Lecturer on the College of Aberdeen, defined: “As the necessity for extra individualised approaches to endometriosis administration turns into more and more clear, the supply of a further therapeutic choice represents an necessary advance. It’s encouraging to see ladies in Scotland getting access to new remedy choices, and I hope ongoing analysis will proceed to broaden the alternatives out there.”
Sandy Lindsey, UK Common Supervisor at Theramex, mentioned: “There are too many ladies who’re residing with ache resulting from their endometriosis. With the SMC approval of linzagolix we will now supply a further remedy choice to ladies in Scotland, empowering clinicians and sufferers with extra decisions. This approval by the SMC is a vital step on a for much longer journey in direction of entry to improved remedy for endometriosis throughout the UK.”
Emma Cox, Chief Government at Endometriosis UK, added: “Endometriosis UK welcomes the addition of Linzagolix to the vary of accredited therapies for endometriosis in Scotland. It’s very important sufferers are in a position to make knowledgeable decisions about what remedy choices are proper for them.”
Linzagolix with add-back Remedy accepted to be used inside NHS Scotland
Ladies in Scotland affected by endometriosis now have entry to a brand new remedy choice following the Scottish Medicines Consortium’s (SMC) acceptance of linzagolix with add-back remedy (ABT). The once-daily tablet is accredited for grownup ladies of reproductive age who’ve beforehand undergone medical or surgical remedy for the situation.
The choice aligns NHS Scotland with the remainder of the UK, the place linzagolix has already been accredited by the Nationwide Institute for Well being and Care Excellence (NICE) to be used in England, Wales and Northern Eire. Endometriosis impacts round one in ten ladies of reproductive age within the UK and may trigger continual pelvic ache, painful menstruation and important impacts on high quality of life.
Dr Fortunate Saraswat, Guide Gynaecologist and Honorary Senior Lecturer on the College of Aberdeen, defined: “As the necessity for extra individualised approaches to endometriosis administration turns into more and more clear, the supply of a further therapeutic choice represents an necessary advance. It’s encouraging to see ladies in Scotland getting access to new remedy choices, and I hope ongoing analysis will proceed to broaden the alternatives out there.”
Sandy Lindsey, UK Common Supervisor at Theramex, mentioned: “There are too many ladies who’re residing with ache resulting from their endometriosis. With the SMC approval of linzagolix we will now supply a further remedy choice to ladies in Scotland, empowering clinicians and sufferers with extra decisions. This approval by the SMC is a vital step on a for much longer journey in direction of entry to improved remedy for endometriosis throughout the UK.”
Emma Cox, Chief Government at Endometriosis UK, added: “Endometriosis UK welcomes the addition of Linzagolix to the vary of accredited therapies for endometriosis in Scotland. It’s very important sufferers are in a position to make knowledgeable decisions about what remedy choices are proper for them.”












